Phlebodia 600 (Diosmin) 18 tablets

Instructions for Phlebodia 600 (Diosmin) 18 tablets

English product name
Phlebodia 600

Release Form
Film-coated tablets

Description Phlebodia 600

The tablets, covered with a film shell of pink color, are round, double-convex.

1 tab.
dry substance diosmin 600 mg
Auxiliary substances: talc - 10.24 mg, silicon dioxide colloidal - 3.5 mg, stearic acid - 50.05 mg, cellulose microcrystalline - up to 910 mg.

Film sheath composition: Sepifield® 002 (hypromellose (E 464) - 9.832 mg, cellulose microcrystalline - 7.866 mg, macrogol 8 stearate type 1 - 1.967 mg); Sepispers® AP 5523 pink (propylene glycol - traces, hypromellose (E 464) - 0.458 mg, titanium dioxide (E 171) - 4.026 mg, powder dye [Ponso 4R] (E 4R)) E 124) - 0.401 mg, iron oxide black (E 172) - 0.13 mg, iron oxide red (E 172) - 0.02 mg); Opaglos® 6000 (Carnauba wax (E 903) - 0.075 mg, beeswax (E 901) - 0.075 mg, shellac (E 904) - 0.15 mg, ethanol 95° - traces).

ATC codes Diosmin
C05CA03 Diosmin

Clinical-pharmacological groups / Group affiliation Diosmin
Angioprotective preparation

Active substance 
diosmin

Pharmaco-therapeutic group Phlebodia 600

Angioprotective agent

Storage Conditions Diosmin
The drug should be stored in a place inaccessible to children at a temperature not higher than 30 ° C.

Best before date Diosmin
Expiration date is a year. Do not apply after expiry date.

Pharmacological effect Phlebodia 600

Venotonising action: reduces the stretching of veins, increases the tonus of veins, reduces the venous stasis, enhances the vasoconstricting effect of adrenaline, noradrenaline. One tablet contains 600 mg of diosmin, which is the optimal daily dose for the venotonizing effect.

Angioprotective action: improves microcirculation; increases capillary resistance; reduces permeability.

Testimony Phlebodia 600

Treatment of symptoms of lower limb lymphovenous insufficiency (feeling of heaviness, tiredness, opening in legs; pain, which increases by the end of the day; swelling);
Additional treatment for microcirculation disorders;
treatment of symptoms of acute hemorrhoids.

Method of use, course and dosage Phlebodia 600

The drug is intended for ingestion.
For chronic lymphovenous insufficiency, one tabb/day is prescribed in the morning, preferably before meals. The duration of therapy is usually 2 months.

• Nosology Phlebodia 600 (ICD codes)
• I78.8
• Other capillary diseases
• I87.2
• Venous insufficiency (chronic) (peripheral)
• I89.0
• Lymphoedema not classified in other categories
• K64
• Hemorrhoids and perianal venous thrombosis